Risk assessment of di(2-ethylhexyl)phthalate released from PVC blood circuits during hemodialysis and pump-oxygenation therapy

International Journal of Pharmaceutics

Volumn 274, Issue 1-2, 2004, Pages 119-129

  Haishima, Yuji ^a   Matsuda, Rieko ^a   Hayashi, Yuzuru ^a   Hasegawa, Chie ^a   Yagami, Takeshi ^a   Tsuchiya, Toshie ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Blood circuit; DEHP; Hemodialysis; MEHP; Pump oxygenator; PVC tubing

Indexed keywords

HEPARIN; PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; POLYVINYLCHLORIDE;

ARTICLE; CATTLE; CHEMICAL BOND; CIRCULATION; DIALYSIS MEMBRANE; DRUG ELIMINATION; DRUG EXPOSURE; GAS CHROMATOGRAPHY; HEMODIALYSIS; HYDROLYSIS; MASS SPECTROMETRY; NONHUMAN; OXYGEN THERAPY; OXYGENATION; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TIME;

ADULT; ANIMALS; CATTLE; DIETHYLHEXYL PHTHALATE; HUMANS; POLYVINYL CHLORIDE; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 1842505311     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.01.009     Document Type: Article

References (39)

1. Allwod M.C. The release of phthalate ester plasticizer from intravenous administration sets into fat emulsion. Int. J. Pharm. 29:1986;233-236.
2. Center for Devices and Radiological Health, 2001. Safety assessment of di(2-ethylhexyl)phthalate (DEHP) released from PVC medical devices. US Food and Drug Administration, 4 September.
3. David R.M., Moore M.R., Cifone M.A., Finney D.C. Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol. Sci. 50:1999;195-205.
4. Davis B.J., Maronpot R.R., Heindel J.J. Di-(2-ethylhexyl)phthalate suppressed estradiol and ovulation in cycling rats. Toxicol. Appl. Pharmacol. 128:1994;216-223.
5. Doull J., Cattley R., Elcombe C., Lake B.G., Swenberg J., Wilkinson C., van Gemert M. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new US EPA risk assessment guidelines. Reg. Toxicol. Pharm. 29:1999;327-357.
6. Faouzi M.A., Dine T., Gressier B., Kambia K., Luyckx M., Pagniez D., Brunet C., Cazin M., Belabed A., Cazin J.C. Exposure of hemodialysis patients to di-2-ethylhexyl phthalate. Int. J. Pharm. 25:1999;113-121.
7. Flaminio L.M., Bergia R., De Angelis L., Ferazza M., Marinovich M., Galli G., Galli C.L. The fate of leached di-(2-ethylhexyl)-phthalate (DEHP) in patients on chronic haemodialysis. Int. J. Artif. Organs. 11:1988;428-434.
8. Grasso P., Heindel J.J., Powell C.J., Reichert L.E. Effects of mono(2-ethylhexyl)phthalate, a testicular toxicant, on follicle-stimulating hormone binding to membranes from cultured rat Sertoli cells. Biol. Reprod. 48:1993;454-459.
9. Haishima Y., Hayashi Y., Yagami T., Nakamura A. Elution of bisphenol-A from hemodialyzers consisting of polycarbonate and polysulfone resins. J. Biomed. Mater. Res. (Appl. Biomater.). 58:2001;209-215.
10. Hanawa T., Muramatsu E., Asakawa K., Suzuki M., Tanaka M., Kawano K., Seki T., Juni K., Nakajima S. Investigation of the release behavior of diethylhexyl phthalate from the polyvinyl-chloride tubing for intravenous administration. Int. J. Pharm. 210:2000;109-115.
11. Hayashi Y., Matsuda R. Deductive prediction of measurement precision from signal and noise in liquid chromatography. Anal. Chem. 66:1994;2874-2881.
12. Hayashi Y., Matsuda R., Haishima Y., Yagami T., Nakamura A. Validation of HPLC and GC-MS systems for bisphenol-A leached from hemodialyzers on the basis of FUMI theory. J. Pharm. Biomed. Anal. 28:2002;421-429.
13. Hayashi Y., Matsuda R., Poe R.B. Probabilistic approach to confidence intervals of linear calibration. Analyst. 121:1996;591-599.
14. Heindel J.J., Chapin R.E. Inhibition of FSH-stimulated camp accumulation by mono(2-ethylhexyl)phthalate in primary rat Sertoli cell cultures. Toxicol. Appl. Pharmacol. 97:1989;377-385.
15. ICH Guidelines, 1996. Validation of analytical procedures: methodology, ICH Topics Q2B.
16. Inoue K., Kawaguchi M., Okada F., Yoshimura Y., Nakazawa H. Column-switching high-performance liquid chromatography electrospray mass spectrometry coupled with on-line of extraction for the determination of mono- and di-(2-ethylhexyl) phthalate in blood samples. Anal. Bioanal. Chem. 375:2003;527-533.
17. Inoue K., Higuchi T., Okada F., Iguchi H., Yoshimura Y., Sato A., Nakazawa H. The validation of column-switching LC/MS as a high-throughput approach for direct analysis of di(2-ethylhexyl)phthalate released from PVC medical devices in intravenous solution. J. Pharm. Biomed. Anal. 31:2003;1145-1152.
18. Kambia K., Dine T., Azar R., Gressier B., Luyckx M., Brunet C. Comparative study of the leachability of di(2-ethylhexyl)phthalate and tri(2-ethylhexyl)trimellitate from haemodialysis tubing. Int. J. Pharm. 23:2001;139-146.
19. Karle V.A., Short B.L., Martin G.R., Bulas D.I., Getson P.R., Luban N.L., O'Brien A.M., Rubin R.J. Extracorporeal membrane oxygenation exposes infants to the plasticizer, di(2-ethylhexyl)phthalate. Crit. Care Med. 25:1997;696-703.
20. Koizumi M., Hirose A., Hasegawa R. Recent studies on toxic effects of phthalate esters on reproduction and development: focus on di(2-ethylhexyl) phthalate and di-n-butyl phthalate. Jpn. J. Food Chem. 7:2000;65-73.
21. Lake B.G., Phillips J.C., Linnel J.C., Gangolli S.D. The in vitro hydrolysis of some phthalate diesters by hepatic and intestinal preparations from various species. Toxicol. Appl. Pharmacol. 39:1977;239-248.
22. Lamb J.C., Chapin R.E., Teague J., Lawton A.D., Reel J.R. Reproductive effects of four phthalic acid esters in the mouse. Toxicol. Appl. Pharmacol. 88:1987;255-269.
23. Lamba N.M., Courtney J.M., Gaylor J.D., Lowe G.D. In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response. Biomaterials. 21:2000;89-96.
24. Lee J., Richburg J.H., Shipp E.B., Meistrich M.L., Boekelheide K. The Fas system, a regulator of testicular germ cell apoptosis, is deferentially up-regulated in Sertoli cell versus germ cell injury of the testis. Endocrinology. 140:1999;852-858.
25. Lewis L.M., Flechtner T.W., Kerkay J., Pearson K.H., Nakamoto S. Bis(2-ethylhexyl)phthalate concentrations in the serum of hemodialysis patients. Clin. Chem. 24:1978;741-746.
26. Loff S., Kabs F., Witt K., Sartoris J., Mandl B., Niessen K.H., Waag K.L. Polyvinylchloride infusion lines expose infants to large amounts of toxic plasticizers. J. Pediatr. Surg. 35:2000;1775-1781.
27. Lovekamp T.N., Davis B.J. Mono-(2-ethylhexyl)phthalate suppresses aromatase transcript levels and estradiol production in cultured rat granulosa cells. Toxicol. Appl. Pharmacol. 172:2001;217-224.
28. Mejak B.L., Stammers A., Rauch E., Vang S., Viessman T. A retrospective study on perfusion incidents and safety devices. Perfusion. 15:2000;51-61.
29. Muramatsu E., Hanawa T., Suzuki M., Tanaka M., Kawano K., Nakajima S. Investigation of the effect of the coexistence of surfactant on the release behavior of diethylhexyl phthalate from polyvinyl chloride tubing. Jpn. J. Hosp. Pharm. 26:2000;471-477.
30. Pollack G.M., Buchanan J.F., Slaughter R.L., Kohli R.K., Shen D.D. Circulating concentrations of di(2-ethylhexyl)phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysis. Toxicol. Appl. Pharmacol. 79:1985;257-267.
31. Poon R., Lecavalier P., Mueller R., Valli V.E., Procter B.G., Chu I. Subchronic oral toxicity of di-n-octyl phthalate and di(2-ethylhexyl)phthalate in the rat. Food Chem. Toxicol. 35:1997;225-239.
32. Rhodes C., Orton T.C., Pratt I.S., Batten P.L., Bratt H., Jackson S.J., Elcombe C.R. Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl)phthalate (DEHP) in rats and marmosets. Environ. Health Perspect. 65:1986;299-307.
33. Richburg J.H., Boekelheide K. Mono-(2-ethylhexyl)phthalate rapidly alters both Sertoli cell vimentin filaments and germ cell apoptosis in young rat testes. Toxicol. Appl. Pharmacol. 137:1996;42-50.
34. Richburg J.H., Nanex A., Williams L.R., Embree M.E., Boekelheide K. Sensitivity of testicular germ cells to toxicant-induced apoptosis in gld mice that express a nonfunctional form of Fas ligand. Endocrinology. 141:2000;787-793.
35. Tanaka M., Kawano K., Hanawa T., Suzuki M., Nakajima S. Dissolution of DEHP from PVC administration tube: estimation of DEHP dissolution based on HCO60 concentration and drip conditions. Jpn. J. Health Care. 27:2001;132-136.
36. Tickner J.A., Schettler T., Guidotti T., McCally M., Rossi M. Health risks posed by use of di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review. Am. J. Ind. Med. 39:2001;100-111.
37. Tyl R.W., Price C.J., Marr M.C., Kimmel C.A. Developmental toxicity evaluation of dietary di(2-ethylhexyl)phthalate in Fischer 344 rats and CD-1 mice. Fundam. Appl. Toxicol. 10:1988;395-412.
38. Woodward, K.N., 1988. Phthalate Esters: Toxicity and Metabolism, vol. II. CRC Press, Boca Raton, FL.
39. Zacharewski T.R., Meek M.D., Clemons J.H., Wu Z.F., Fielden M.R., Mathews J.B. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters. Toxicol. Sci. 46:1998;282-293.